TY  - JOUR
AU  - Humanes, Blanca
AU  - Lázaro Fernández, Alberto
AU  - Camano, Sonia
AU  - Moreno Gordaliza, María Estefanía
AU  - Lázaro, José A.
AU  - Blanco Codesido, Montserrat
AU  - Lara, José M.
AU  - Ortiz, Alberto
AU  - Gómez Gómez, María Milagros
AU  - Martín Vasallo, Pablo
AU  - Tejedor Jorge, Alberto
PY  - 2012
DO  - 10.1038/ki.2012.199
SN  - 0085-2538
UR  - https://hdl.handle.net/20.500.14352/42741
T2  - Kidney International
AB  - Cisplatin is an anticancer agent marred by nephrotoxicity; however, limiting this adverse effect may allow the use of higher doses to improve its efficacy. Cilastatin, a small molecule inhibitor of renal dehydropeptidase I, prevents proximal tubular...
LA  - eng
M2  - 652
PB  - International Society of Nephrology
KW  - Apoptosis
KW  - Cilastatin
KW  - Cisplatin
KW  - Nephroprotection
KW  - Nephrotoxicity
TI  - Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats
TY  - journal article
VL  - 82
ER  -